Titrating CD47 by mismatch CRISPRi reveals incomplete repression can eliminate IgG-opsonized tumors but CD47 heterogeneity limits induction of anti-tumor IgG
B. H. Hayes, H. Zhu, J. C. Andrechak, D. E. Discher
This study uses CRISPRi to titrate CD47 in melanoma cells, showing that incomplete repression can eliminate opsonized tumors but CD47 heterogeneity limits anti-tumor IgG induction.
bioRxiv · Sep 27, 2022 · PreprintCancer Biology